Terms: = Sarcomas AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
5 results:
1. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological analysis and genomic profiling of a rare histiocyte-rich rhabdomyoblastic tumor: A case report.
Xia Y; Li Y; Gong P; Jiang H; Zhang X
Medicine (Baltimore); 2021 Jun; 100(24):e26105. PubMed ID: 34128847
[TBL] [Abstract] [Full Text] [Related]
3. Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathway.
Tian H; Zhou T; Chen H; Li C; Jiang Z; Lao L; Kahn SA; Duarte MEL; Zhao J; Daubs MD; Buser Z; Brochmann EJ; Wang JC; Murray SS
J Orthop Res; 2019 Jul; 37(7):1638-1648. PubMed ID: 30737824
[TBL] [Abstract] [Full Text] [Related]
4. Down regulation of Wnt signaling mitigates hypoxia-induced chemoresistance in human osteosarcoma cells.
Scholten DJ; Timmer CM; Peacock JD; Pelle DW; Williams BO; Steensma MR
PLoS One; 2014; 9(10):e111431. PubMed ID: 25347326
[TBL] [Abstract] [Full Text] [Related]
5. The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines.
Stratford EW; Daffinrud J; Munthe E; Castro R; Waaler J; Krauss S; Myklebost O
Cancer Med; 2014 Feb; 3(1):36-46. PubMed ID: 24403055
[TBL] [Abstract] [Full Text] [Related]